Cittadine Andrew
Chief Operating Officer · 10 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | MNPR | Monopar Therapeutics | Tax withholding | 2,309 | $92.59 | $213,790.31 | filing |
| 2026-06-30 | MNPR | Monopar Therapeutics | Option exercise | 5,254 | — | — | filing |
| 2026-03-31 | MNPR | Monopar Therapeutics | Tax withholding | 1,571 | $54.79 | $86,075.09 | filing |
| 2026-03-31 | MNPR | Monopar Therapeutics | Option exercise | 3,514 | — | — | filing |
| 2025-12-31 | MNPR | Monopar Therapeutics | Tax withholding | 1,889 | $65.30 | $123,351.70 | filing |
| 2025-12-31 | MNPR | Monopar Therapeutics | Option exercise | 4,326 | — | — | filing |
| 2025-09-30 | MNPR | Monopar Therapeutics | Tax withholding | 1,896 | $81.67 | $154,846.32 | filing |
| 2025-09-30 | MNPR | Monopar Therapeutics | Option exercise | 4,327 | — | — | filing |
| 2025-06-30 | MNPR | Monopar Therapeutics | Tax withholding | 2,990 | $35.78 | $106,982.20 | filing |
| 2025-06-30 | MNPR | Monopar Therapeutics | Option exercise | 6,863 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.